title: Addressing the innovation gap.
abstract: The 10 years since the mid-1990s have witnessed an unprecedented investment in Drug Discovery driven by both the unraveling of the human genome and the parallel introduction of various high-throughput technologies. During the same period, industry metrics describe a decline in the numbers of new molecular entities launched upon the global pharmaceutical markets. The Society for Medicines Research (SMR) meeting entitled "Addressing the Innovation Gap" brought together a program of expert speakers to comment upon the challenges currently facing the pharmaceutical industry and some of the measures being undertaken to enable future success.
authors.affiliation: Society for Medicines Research (SMR) Committee, Thurmaston, Leicester, UK. secretariat@smr.org.uk
authors.forename: Phillip
authors.initials: P
authors.lastname: Jeffrey
authors.forename: Peter
authors.initials: P
authors.lastname: Warne
authors.forename: Robert
authors.initials: R
authors.lastname: Williams
mesh_terms: D004059:Diffusion of Innovation; D000939:Epitopes; D048088:Informatics; D010600:Pharmacology / Q000639:trends*
chemical_list: D000939:Epitopes